http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813750-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dc3ebcd961f6eeb67939eed79ecf972
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
filingDate 2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54eebc6439b76d7d836fe6a33fecef14
publicationDate 2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10813750-B2
titleOfInvention Mitral valve prosthesis for transcatheter valve implantation
abstract A transcatheter valve prosthesis is disclosed that has a compressed, delivery configuration and an expanded configuration for deployment within a native heart valve. The valve prosthesis includes a self-expanding frame and a prosthetic valve component. The self-expanding frame includes a valve receiving portion defining an opening therethrough and first and second anchors at opposing ends of the valve receiving portion. The valve receiving portion is substantially planar and the first and second anchors are oriented substantially perpendicular to the valve receiving portion when the valve prosthesis is in the expanded configuration. The prosthetic valve component is disposed within the opening of the valve receiving portion and secured thereto.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11259923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510769-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446144-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406497-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D968607-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285001-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11589984-B2
priorityDate 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006195183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013076724-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013028387-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008063537-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6190311-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012203336-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443032

Total number of triples: 38.